Glucose Baxter (Glucose Monohydrate)

Glucose Baxter is used in clinical settings where rapid carbohydrate delivery is required. It serves several supportive roles during patient care.

• Provides an immediate source of glucose for patients unable to ingest food orally.
• Assists in maintaining fluid and electrolyte balance during surgery or critical illness.
• Supports energy metabolism in patients receiving total parenteral nutrition.
• Helps prevent hypoglycemia in patients on insulin therapy or fasting.
• Used as a diluent for certain intravenous medications that require a carbohydrate carrier.

Glucose Baxter may be associated with a range of adverse reactions, most of which are related to its glucose content and the intravenous route.

Common

• Transient hyperglycemia or elevated blood glucose levels.
• Local irritation or pain at the infusion site.
• Mild nausea or vomiting.
• Headache or dizziness.
• Fluid overload when administered in large volumes.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic or anaphylactic reaction (rash, itching, swelling, difficulty breathing).
• Electrolyte imbalance, particularly hyponatremia.
• Venous thrombosis or phlebitis at the catheter site.

When using Glucose Baxter, healthcare professionals should consider several safety measures to minimize risk.

• Monitor blood glucose levels before, during, and after infusion, especially in diabetic patients.
• Assess fluid status and avoid excessive volumes in patients with heart failure or renal impairment.
• Use aseptic technique to prevent catheter-related infections.
• Verify compatibility with other IV medications before co‑administration.
• Adjust infusion rate in neonates, infants, and patients with compromised metabolic capacity.
• Document any adverse reactions promptly and report severe events to pharmacovigilance.

Glucose Baxter can interact with other agents that affect blood glucose or fluid balance.

Avoid

• Concurrent high‑dose insulin therapy without close glucose monitoring.
• Co‑administration with other hyperosmolar glucose solutions that may exacerbate hyperglycemia.
• Use with medications that cause fluid retention in patients at risk of overload.

Use with caution

• Diuretics, which may alter electrolyte status when combined with large glucose infusions.
• Beta‑blockers, which can mask signs of hypoglycemia.
• Corticosteroids, which may increase glucose production and raise blood sugar levels.
• Certain antibiotics (e.g., aminoglycosides) that require careful fluid management.